| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.01 |